Pitavastatin Cuts Risk of Cardiovascular Events in Patients With HIV
Significant reduction seen in incidence of major adverse cardiovascular events over median follow-up of 5.1 years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.